{"id":24887,"date":"2025-04-23T09:00:00","date_gmt":"2025-04-23T09:00:00","guid":{"rendered":"https:\/\/www.caplinpoint.net\/?p=24887"},"modified":"2025-06-24T04:51:14","modified_gmt":"2025-06-24T04:51:14","slug":"caplin-steriles-gets-usfda-approval-for-phytonadione-injectable-emulsion","status":"publish","type":"post","link":"https:\/\/www.caplinpoint.net\/index.php\/2025\/04\/23\/caplin-steriles-gets-usfda-approval-for-phytonadione-injectable-emulsion\/","title":{"rendered":"CAPLIN STERILES GETS USFDA APPROVAL FOR PHYTONADIONE INJECTABLE EMULSION"},"content":{"rendered":"\n<p><strong>Chennai, April 23, 2025: Caplin Steriles Limited (Caplin), <\/strong>a Subsidiary Company of Caplin Point Laboratories Limited (BSE: CAPPL (524742), NSE: CAPLIPOINT), has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Phytonadione Injectable Emulsion USP, 10 mg\/mL, Single Dose Vial, a generic therapeutic equivalent version of the Reference Listed Drug (RLD) VITAMIN K1 Injection, from Hospira Inc.<\/p>\n\n\n\n<p>Phytonadione Injectable Emulsion possesses the same type and degree of activity as does naturally-occurring vitamin K and is indicated for coagulation disorders which are due to faulty formation of factors II, VII, IX and X when caused by vitamin K deficiency or interference with vitamin K activity. According to IQVIATM (IMS Health), Phytonadione Injectable Emulsion had US sales of approximately $18.5 million for the 12-month period ending February 2025.<\/p>\n\n\n\n<div class=\"wp-block-file\"><a target=\"_blank\" href=\"https:\/\/www.caplinpoint.net\/wp-content\/uploads\/2025\/04\/Press_Release_sd.pdf\" class=\"wp-block-file__button\" rel=\"noopener\">Source<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Chennai, April 23, 2025: Caplin Steriles Limited (Caplin), a Subsidiary Company of Caplin Point Laboratories Limited (BSE: CAPPL (524742), NSE: CAPLIPOINT), has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Phytonadione Injectable Emulsion USP, 10 mg\/mL, Single Dose Vial, a generic therapeutic equivalent&#8230; <\/p>\n","protected":false},"author":1,"featured_media":1229,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/posts\/24887"}],"collection":[{"href":"https:\/\/www.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/comments?post=24887"}],"version-history":[{"count":1,"href":"https:\/\/www.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/posts\/24887\/revisions"}],"predecessor-version":[{"id":24888,"href":"https:\/\/www.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/posts\/24887\/revisions\/24888"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/media\/1229"}],"wp:attachment":[{"href":"https:\/\/www.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/media?parent=24887"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/categories?post=24887"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/tags?post=24887"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}